Search results for "DIABETES MELLITUS"

showing 10 items of 2077 documents

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

2018

For some time, it has been assumed that women with polycystic ovary syndrome (PCOS) are at increased risk of developing cardiovascular disease (CVD). This has largely been on the basis of having many risk factors, including abnormal lipid profile, insulin resistance, and markers of inflammation. However, despite having these and other risk factors, we argue here, in the view of the authors, that there is no credible evidence that there is greater CVD morbidity in all women with PCOS. We analyze the existing data and discuss that overall CVD risk decreases with age when more CVD events are likely to occur, and introduce the possibility that there may be some unknown inherent protective facto…

Adultmedicine.medical_specialtyendocrine system diseasesProtective factor030209 endocrinology & metabolismDiseaseRisk Assessment03 medical and health sciences0302 clinical medicineInsulin resistanceRisk FactorsDiabetes mellitusmedicineDiabetes MellitusHumansObesityMenstruation Disturbances030219 obstetrics & reproductive medicinebusiness.industryObstetricsHyperandrogenismAbsolute risk reductionnutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryObesityfemale genital diseases and pregnancy complicationsCardiovascular DiseasesFemalebusinessHyperandrogenismRisk Reduction BehaviorPolycystic Ovary SyndromeJournal of women's health (2002)
researchProduct

Effects of a HIIT Protocol on Cardiovascular Risk Factors in a Type 1 Diabetes Mellitus Population

2021

Cardiovascular complications are important causes of morbidity and mortality of Type 1 Diabetes Mellitus (T1DM) people. Regular exercise is strongly recommended to these patients due to its preventive action against this type of disease. However, a large percentage of patients with T1DM people present a sedentary behavior, mainly, because of the fear of a post-exercise hypoglycemia event and lack of time. High-intensity interval training (HIIT) is an efficient and safe methodology since it prevents hypoglycemia and does not require much time, which are the main barriers for this population to doing exercise and increasing physical conditioning. Nineteen sedentary adults (37 ± 6.5 years) wit…

Adultmedicine.medical_specialtyendocrine system diseasestype 1 diabetesHealth Toxicology and MutagenesisPopulationlcsh:Medicine030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyHypoglycemiaArticleInterval training03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansHeart rate variabilityeducationhigh-intensity interval trainingRandomized Controlled Trials as TopicType 1 diabeteseducation.field_of_studyexercisebusiness.industrylcsh:RPublic Health Environmental and Occupational Healthnutritional and metabolic diseasesmedicine.diseaseDiabetes Mellitus Type 1Cardiovascular DiseasesHeart Disease Risk Factorsbusinesshuman activitiesHigh-intensity interval trainingInternational Journal of Environmental Research and Public Health
researchProduct

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort

2021

Abstract Aims To estimate the attributable risk of renal function on all-cause mortality and cardiovascular hospitalization in patients with diabetes. Methods A prospective cohort study in 19,469 adults with diabetes, free of cardiovascular disease, attending primary care in Spain (2008–2011). The estimated glomerular filtration rate (eGFR) and other variables were collected and patients were followed to the first hospitalization for coronary or stroke event, or death, until the end of 2012. The cumulative incidence of the study endpoints by eGFR categories was graphically displayed and adjusted population attributable risks (PARs) for low eGFR was calculated. Results Mean follow-up was 3.2…

Adultmedicine.medical_specialtyhypertensionkidney dysfunctionEndocrinology Diabetes and MetabolismPopulationRenal function030209 endocrinology & metabolismKidneyCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusattributable riskDiabetes MellitusInternal MedicinemedicineHumansCumulative incidenceProspective StudiesRegistries030212 general & internal medicineRenal Insufficiency ChronicProspective cohort studyeducationStrokeeducation.field_of_studyNutrition and Dieteticsbusiness.industrymedicine.diseasemortalitycardiovascular diseasesHospitalizationCardiovascular Diseasesdiabetes mellitusAttributable riskCohortFamily PracticebusinessGlomerular Filtration RatePrimary Care Diabetes
researchProduct

Comparison of the effect of ginger and aloe vera mouthwashes on xerostomia in patients with type 2 diabetes: A clinical trial, triple-blind

2021

Background Ginger and aloe vera are two medicinal herbs mostly used to produce mouthwash. This study aimed to compare the effects of ginger and aloe vera mouthwashes on the xerostomia in patients referred to Bandar Abbas diabetes clinic (Iran). Material and Methods In this triple-blind clinical trial, three groups (n=35 patients in each group) were studied. One group was given aloe vera mouthwash, the other group used ginger mouthwash, and the control group was only given normal saline. All the mouthwashes were used 20 ccs three times daily for 14 consecutive days. The symptoms and severity of xerostomia were measured before and after the intervention by the questionnaire proposed by Fox et…

Adultmedicine.medical_specialtymedicine.medical_treatmentMouthwashesType 2 diabetesGingerIranXerostomiaAloe veralaw.inventionMcNemar's testbone regenerationstomatognathic systemRandomized controlled triallawInternal medicineDiabetes mellitusHumansMedicineIn patientthird molarxenograftAloeGeneral DentistrySalineUNESCO:CIENCIAS MÉDICASAgedtooth extractionOral Medicine and Pathologybiologybusiness.industryResearchMiddle Agedbiology.organism_classificationmedicine.diseaseClinical trialDiabetes Mellitus Type 2OtorhinolaryngologySurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Contraception in diabetic women: an Italian study

2005

Abstract Over 1 year, a survey on contraception and obstetric history was performed on a cohort of 667 Caucasian fertile diabetic women (446, type 1 and 201, type 2) living in Italy. Results: Of these women, 30.4% used hormonal contraceptives, 12.0% intra-uterine device (IUD), 10.7% declared they used no contraception, 47.0% only utilised barrier and/or natural methods. However, irrespective of their previous contraceptive strategy, 7.2% of all the studied population was surgically sterilized during caesarean section. Hormonal contraception: Of these women, 60.4% was prescribed by a gynaecologist, 11.2% by a diabetologist, 15% by both of them and 13.4% by others. The proportion using oral c…

Adultmedicine.medical_specialtytype 1 diabetesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationdiabetic pregnancycontraception; diabetic pregnancy; type 1 diabetes; type 2 diabetesWhite PeopleCohort StudiesEndocrinologyInternal MedicinemedicineHumansCaesarean sectioneducationGynecologyPregnancyeducation.field_of_studyDiabetic RetinopathyGeographyMarital Statusbusiness.industryObstetricsSmokingGeneral Medicinemedicine.diseaseDiabetes Mellitus Type 1Diabetes Mellitus Type 2ItalycontraceptionHormonal contraceptionFamily planningCohortFemaletype 2 diabetesbusinessDeveloped countryCohort studyDiabetes Research and Clinical Practice
researchProduct

No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.

2013

Context: Women with type 1 diabetes mellitus (DM1) have a higher prevalence of polycystic ovary syndrome (PCOS) than the general population. Objective: The aim of this study was to clarify, in DM1 women with PCOS(PCOS-DM1), the influence of insulin therapy and glycemic control and evaluate the hormonal and phenotypic differences with age-matched and body mass index (BMI)-matched women with PCOS without diabetes. Design, Setting, and Patients: We evaluated 103 DM1 women with and without PCOS treated with intensive insulin therapy; 38 age-matched and BMI-matched women with PCOS without diabetes were compared in a cross-sectional study. Outcome Measurements: Clinical, anthropometric, and metab…

Adultmusculoskeletal diseasesPCOS Type 1 Diabetescongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectClinical BiochemistryPopulationContext (language use)BiochemistryBody Mass IndexSettore MED/13 - EndocrinologiaYoung AdultEndocrinologyInternal medicineDiabetes mellitusPrevalencemedicineHumanseducationReproductive HistoryMenstrual cyclemedia_commoneducation.field_of_studyType 1 diabetesbusiness.industryPolycystic ovary syndrome (PCOS)Biochemistry (medical)nutritional and metabolic diseasesmedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsCross-Sectional StudiesDiabetes Mellitus Type 1PhenotypeEndocrinologyCase-Control StudiesFemalebusinessBody mass indexPolycystic Ovary Syndrome
researchProduct

Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: the SAGE study

2021

International audience; Aims: This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions.Materials and methods: SAGE was a multinational, cross-sectional, observational study in adults with T1DM. Data were collected at a single visit, analysed according to predefined age groups (26-44, 45-64, and ≥65 years), and reported across different regions. PRO questionnaires were applied to assess hypoglycaemia fear (Hypoglycemia Fear Survey-II [HFS-II]), diabetes-related distress (Problem Areas In Diabetes [PAID]), insulin treatment satisfacti…

Adulttype 1 diabetesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentmedia_common.quotation_subject[SDV]Life Sciences [q-bio]030209 endocrinology & metabolism030204 cardiovascular system & hematologyHypoglycemia03 medical and health sciences0302 clinical medicineEndocrinologyQuality of life (healthcare)Diabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinPatient Reported Outcome Measuresmedia_commonAged[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismGlycated HemoglobinType 1 diabetes[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryInsulin[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Agedmedicine.disease3. Good health[SDV] Life Sciences [q-bio]DistressCross-Sectional StudiesDiabetes Mellitus Type 1glycaemic controlQuality of LifeObservational studyobservational studyWorrybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyClinical psychologyhypoglycaemia
researchProduct

NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke

2019

Background and Purpose— Ischemic stroke causes major disability as a consequence of neuronal loss and recurrent ischemic events. Biomarkers predicting tissue damage or stroke recurrence might be useful to guide an individualized stroke therapy. NfL (neurofilament light chain) is a promising biomarker that might be used for this purpose. Methods— We used individual data of patients with an acute ischemic stroke and clinical long term follow-up. Serum NfL (sNfL) was quantified within 24 hours after admission and after 1 year and compared with other biomarkers (GDF15 [growth differentiation factor 15], S100, NT-proBNP [N-terminal pro-B-type natriuretic peptide], ANP [atrial natriuretic peptid…

Advanced and Specialized Nursing0303 health sciencesmedicine.medical_specialtybusiness.industrymedicine.drug_classOdds ratiomedicine.disease3. Good healthBrain ischemia03 medical and health sciences0302 clinical medicineInterquartile rangeModified Rankin ScaleInternal medicineDiabetes mellitusClinical endpointmedicineNatriuretic peptideCardiologyNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke030217 neurology & neurosurgery030304 developmental biologyStroke
researchProduct

Ambulatory blood pressure for special groups

2000

Advanced and Specialized NursingAmbulatory blood pressurebusiness.industryGeneral MedicineBlood Pressure Monitoring AmbulatoryAssessment and DiagnosisBlood pressureAnesthesiaDiabetes MellitusInternal MedicineHumansMedicineKidney DiseasesCardiology and Cardiovascular MedicinebusinessBlood Pressure Monitoring
researchProduct

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Projec…

2004

To the Editor: Regarding the study by Megherbi et al1 performed to evaluate stroke features, prognosis, and functional outcome in patients with diabetes compared with patients without diabetes, we would like to discuss some issues of potential interest: First, the authors analyzed diabetic patients classified in accordance with WHO diagnostic criteria for diabetes used in 1993 (fasting plasma glucose >140 mg/dL), so it is probably an underestimation of the number of diabetic subjects in the 4537 consecutive patients with ischemic stroke enrolled. Perhaps if they could have classified diabetic patients in accordance with American Diabetes Association (1997)2 criteria (fasting plasma glucose …

Advanced and Specialized NursingAmerican diabetes associationmedicine.medical_specialtybusiness.industryStroke subtypemedicine.diseaseFight-or-flight responseNewly diagnosed diabetesInternal medicineDiabetes mellitusIschemic strokemedicineIn patientNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke
researchProduct